Nevrargenics Ltd
PrivateLast Round
VC Round
Apr 17, 2024
Est. Valuation
$25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nevrargenics Ltd operates in Healthcare & Life Sciences and is based in Sedgefield. Its latest recorded funding round was a Seed round in December 2019.
Nevrargenics Ltd is a biotechnology company that specializes in the discovery and development of novel medicines, specifically retinoic acid receptor modulators, for the treatment of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nevrargenics Ltd Comparables
Compare Nevrargenics Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Io Therapeutics, Inc. | 82% | |
| BenevolentAI | 77% | |
| NervGen Pharma Corp. | 76% |
For institutional investors. Book with your work email.
Nevrargenics Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 17, 2024 | ||||
| Seed | Dec 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nevrargenics Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Aberdeen | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- Jul 27, 2026
Monthly visitors increased 151% MoM.
For institutional investors. Book with your work email.
Nevrargenics Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nevrargenics Ltd's valuation, stock price, and market status.
Is Nevrargenics Ltd a public or private company?
Nevrargenics Ltd is a private company.
What is the current stock price of Nevrargenics Ltd?
Nevrargenics Ltd is a private company, so its shares have no public market price. Caplight tracks Nevrargenics Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nevrargenics Ltd worth (valuation)?
Nevrargenics Ltd's valuation is estimated at $25.0M based on funding round data.
Can I buy Nevrargenics Ltd stock?
Nevrargenics Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nevrargenics Ltd's last funding round?
Nevrargenics Ltd's most recent funding round was VC Round on April 17, 2024.
Who are the main investors in Nevrargenics Ltd?
Key investors in Nevrargenics Ltd include University of Aberdeen.
Will Nevrargenics Ltd IPO soon?
No public IPO plans have been announced for Nevrargenics Ltd.
How can I track Nevrargenics Ltd secondary market activity?
Caplight tracks bids, offers, and trades in Nevrargenics Ltd's shares on secondary markets.